# ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

> **NCT00169130** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lymphoma Study Association** · enrollment: 300 (—)

## Conditions studied

- Lymphoma, Large-Cell, Diffuse

## Interventions

- **DRUG:** doxorubicin
- **DRUG:** cyclophosphamide
- **PROCEDURE:** Autologous stem cell transplantation

## Key facts

- **NCT ID:** NCT00169130
- **Lead sponsor:** Lymphoma Study Association
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 300 (—)
- **Last updated:** 2007-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00169130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00169130, "ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00169130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*